Get our free email newsletter

FDA Publishes Discussion Paper on 3D Printing of Medical Devices

The U.S. Food and Drug Administration (FDA) has released a discussion paper on the use of so-called 3D printing technology in the production of medical devices in hospitals and doctors’ offices.

The paper, “3D Printing Medical Devices at the Point of Care (PoC),” provides extensive background on the FDA’s current regulation of devices and 3D printing technologies, as well as key challenges to device safety and effectiveness presented by the use of such technologies. The paper also poses 16 different questions on the 3D printing of medical devices to garner input from the medical device industry, healthcare facilities and providers, and other stakeholders.

The FDA says that stakeholder input will “help build the foundation for an appropriate regulatory approach for 3D printing at the point of care, personalized care for patients and new innovations in this area.”

- Partner Content -

How to Become A Great Compliance Engineering Professional

The journey to becoming an excellent compliance engineering professional is an ongoing process of continuous learning, practical skill development, and unwavering commitment to ensuring product safety, regulatory compliance, and maintaining the highest standards of professional integrity.

Read the FDA’s discussion paper on 3D printing of medical devices.

Comments on the discussion paper can be filed through the Regulations.gov website through February 8, 2022 (reference Docket FDA-2021-N-1272).

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, and check out trending engineering news.

Get our email updates

What's New

- From Our Sponsors -

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, and trending engineering news.